Cholesterol Resources
The following is a list of cholesterol resources and Web sites that you might find helpful. Also included are the primary references we used to build the RealAge Cholesterol Health Assessment and related information. When you click on a link, your browser will launch a new window, and you'll be visiting a third-party site. To return to RealAge, simply close the new window.
General Information
Primary Articles
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update. Smith, S. C. Jr, et al., Circulation 2006 May 16;113(19):2363-2372.
Approach to the diagnosis and management of lipoprotein disorders. Alwaili K. et al., Current Opinion in Endocrinology, Diabetes, and Obesity 2009 Apr;16(2):132-140.
ATP III Guidelines At-A-Glance Quick Desk Reference. NIH National Cholesterol Education Program. May 2001.
Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease. Lee, T. H. et al., Journal of the American Medical Association 2000 Jan 5;283(1):94-98.
Diet and health: what should we eat?. Willett, W. C., Science 1994 Apr 22;264(5158):532-537.
Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. Robson, J. et al., British Medical Journal 2000 Mar 11;320(7236):702-704.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program. Ansell, B. J. et al., Journal of the American Medical Association 1999 Dec 1;282(21):2051-2057.
Evidence-based guidelines for cardiovascular disease prevention in women. Mosca, L. et al., Circulation 2004 Feb 10;109(5):672-693.
High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Kris-Etherton, P. M. et al., American Journal of Clinical Nutrition 1999 Dec;70(6):1009-1015.
Implications of recent clinical trials for the National Cholesterol Education Program Adult Panel III Guidelines. Grundy, S. M. et al., Circulation 2004 Aug 4;44(3):720-732.
Lipoproteins, cardiovascular disease, and death. The Framingham study. Gordon, T. et al., Archives of Internal Medicine 1981 Aug;141(9):1128-1131.
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. Stamler, J. et al., Journal of the American Medical Association 1999 Dec 1;282(21):2012-2018.
Managing abnormal blood lipids: a collaborative approach. Fletcher, B. et al., Circulation 2005 Nov 15;112(20):3184-3209.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Ridker, P. M., Danielson, E., Fonseca, F.A., New England Journal of Medicine 2008 Nov 20;359(21):2195-2207.
Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. Tang, J. L. et al., British Medical Journal 1998 Apr 18;316(7139):1213-1220.
When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Grundy, S. M. et al., Circulation 1997 Mar 18;95(6):1683-1685.
